Merus Labs International (Merus Labs International) Price-to-Operating-Cash-Flow : 11.71 (As of Apr. 26, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Merus Labs International's share price is $1.30. Merus Labs International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 was $0.11. Hence, Merus Labs International's Price-to-Operating-Cash-Flow Ratio for today is 11.71.

The historical rank and industry rank for Merus Labs International's Price-to-Operating-Cash-Flow or its related term are showing as below:

MSLI's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.465
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Merus Labs International's Cash Flow from Operations per share for the three months ended in Mar. 2017 was $0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 was $0.11.

Merus Labs International Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Merus Labs International's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Price-to-Operating-Cash-Flow Chart

Merus Labs International Annual Data

Trend

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

14.42

4.11

6.40

5.36

6.38

Merus Labs International Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															7.46	9.71	6.38	6.37	8.49

Competitive Comparison of Merus Labs International's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merus Labs International's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Price-to-Operating-Cash-Flow falls into.

Merus Labs International Price-to-Operating-Cash-Flow Calculation

Merus Labs International's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.30	/	0.111
	=	11.71

Merus Labs International's Share Price of today is $1.30.
Merus Labs International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Merus Labs International Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Merus Labs International (Merus Labs International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.meruslabs.com

Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines

From GuruFocus

Update on Merus Labs International, Athabasca Minerals Inc, Enghouse Systems Limited, WiLAN Inc.

By Gordon Pape Gordon Pape • 06-22-2015

Merus Labs International: A Pharma Stock With Growth Potential

By Gordon Pape Gordon Pape • 03-30-2015

Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals

By Gordon Pape Gordon Pape • 10-05-2015